Second bone marrow transplantation for patients with thalassemia: risks and benefits
- PMID: 19734431
- PMCID: PMC2738733
- DOI: 10.3324/haematol.2009.006817
Second bone marrow transplantation for patients with thalassemia: risks and benefits
Comment on
-
Allogeneic stem cell transplantation for thalassemia major.Haematologica. 2008 Dec;93(12):1780-4. doi: 10.3324/haematol.2008.001909. Haematologica. 2008. PMID: 19050069 Review. No abstract available.
References
-
- Angelucci E, Baronciani D. Allogeneic stem cell transplantation for thalassemia major. Haematologica. 2008;93:1780–4. - PubMed
-
- Gaziev D, Polchi P, Lucarelli G, Galimberti M, Sodani P, Angelucci E, et al. Second marrow transplants for graft failure in patients with thalassemia. Bone Marrow Transplant. 1999;24:1299–306. - PubMed
-
- Gaziev J, Sodani P, Lucarelli G, Polchi P, Marktel S, Paciaroni K, et al. Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft. Bone Marrow Transplant. 2008;42:397–404. - PubMed
-
- Cheuk DK, Mok AS, Lee AC, Chiang AK, Ha SY, Lau YL, et al. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant. 2008;42:319–27. - PubMed
-
- Rund D, Rachmilewitz E. β-thalassemia. N Engl J Med. 2005;353:1135–46. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
